VR Logo

Piramal Enterprises Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1947

Chairman: Ajay G Piramal

Managing Director: --

Group: Piramal Ajay

Listing: NSE: PEL, BSE: 500302

Headquarters: Mumbai, Maharashtra

Website: www.piramal.com

Key Facts

Market cap: R 24,806.96 Cr

Revenue (TTM): R 14,256.48 Cr

Earnings (TTM): R -463.85 Cr

Cash: R 3,365.16 Cr

Total Debt: R 56,023.26 Cr

Promoters' ownership: 46.06%

Liquidity: High

52 Week range: R 606.85 - 2,137.97

Face value: R2.00

Shares outstanding: 22,55,38,290

10 Years Aggregate:

  • CFO: -54,747.63 Cr
  • EBITDA: 19,258.05 Cr
  • Net Profit: 23,239.66 Cr

Stock Performance

Time Period Piramal Enterprises S&P BSE Healthcare S&P BSE Mid Cap
YTD-25.9817.93-17.55
1 month14.053.292.72
3 months-22.0713.75-16.41
1 Year-48.0417.97-18.98
3 Years-25.524.50-5.87
5 Years3.84-0.113.62
10 Years8.4011.126.02
As on 03-Jun-2020
Year Piramal Enterprises S&P BSE Mid Cap S&P BSE Healthcare
2019-34.84-3.05-3.55
2018-16.36-13.31-5.89
201776.4648.130.49
201660.887.97-12.88
201520.607.4315.06
201451.5754.6947.43
20135.86-5.7322.55